Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Durrington

Showing results (21-30 of 189) with videos related to

Pageof 19
Sort By:
Critical Reviews in Clinical Laboratory Sciences|January 1, 1982
High-density lipoprotein cholesterol: methods and clinical significanceP N Durrington
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1995
Prevention of macrovascular disease: absolute proof or absolute risk?P N Durrington
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1992
Is insulin atherogenic?P N Durrington
Lancet (London, England)|November 27, 1993
How HDL protects against atheromaP N Durrington
BMJ (Clinical Research Ed.)|April 16, 1994
Ischaemic heart disease and cholesterol. Cholesterol reduction effective in established diseaseP N Durrington
Occupational Medicine (Oxford, England)|May 1, 1993
An evaluation of the Reflotron for the determination of plasma cholesterol in capillary blood. Effect of operator variabilityD Bhatnagar, P N Durrington
Lancet (London, England)|February 22, 1992
Wrong lesson from Finnish trial of cardiovascular disease preventionP N Durrington, D Bhatnagar
International Journal of Clinical Practice|June 13, 2003
Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complicationsD Bhatnagar, P N Durrington
Family Practice|December 1, 1990
Coronary risk factors: value of screening and preventive strategies in general practiceD Bhatnagar, P N Durrington
Lancet (London, England)|November 9, 2000
Academia and industryP N Durrington, K Chantler
Pageof 19

Showing results (21-30 of 189) with videos related to

Sort By:
Pageof 19
Critical Reviews in Clinical Laboratory Sciences|January 1, 1982
High-density lipoprotein cholesterol: methods and clinical significanceP N Durrington
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1995
Prevention of macrovascular disease: absolute proof or absolute risk?P N Durrington
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1992
Is insulin atherogenic?P N Durrington
Lancet (London, England)|November 27, 1993
How HDL protects against atheromaP N Durrington
BMJ (Clinical Research Ed.)|April 16, 1994
Ischaemic heart disease and cholesterol. Cholesterol reduction effective in established diseaseP N Durrington
Occupational Medicine (Oxford, England)|May 1, 1993
An evaluation of the Reflotron for the determination of plasma cholesterol in capillary blood. Effect of operator variabilityD Bhatnagar, P N Durrington
Lancet (London, England)|February 22, 1992
Wrong lesson from Finnish trial of cardiovascular disease preventionP N Durrington, D Bhatnagar
International Journal of Clinical Practice|June 13, 2003
Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complicationsD Bhatnagar, P N Durrington
Family Practice|December 1, 1990
Coronary risk factors: value of screening and preventive strategies in general practiceD Bhatnagar, P N Durrington
Lancet (London, England)|November 9, 2000
Academia and industryP N Durrington, K Chantler
Pageof 19